PI3K-gamma/delta

Class

PI3K inhibitor

PI3K-gamma and PI3K-delta are two catalytic isoforms of phosphoinositide 3-kinase, a family of enzymes that convert a membrane lipid (PIP2) into a signaling lipid (PIP3), which in turn switches on the AKT/mTOR pathway controlling cell survival, proliferation, and movement. Unlike the alpha and beta isoforms, which are expressed broadly and support metabolic signaling throughout the body, gamma and delta are concentrated in leukocytes—white blood cells of the innate and adaptive immune system. Gamma is prominent in myeloid cells and drives migration toward sites of inflammation, while delta is central to B-cell and T-cell receptor signaling. Because of this restricted expression pattern, inhibiting gamma and delta together can dampen pathological immune cell activation and proliferation while largely sparing the metabolic functions handled by the alpha and beta isoforms elsewhere in the body. This selectivity rationale underlies interest in dual gamma/delta inhibition for diseases where both innate and adaptive immune compartments contribute to pathology, including chronic inflammatory conditions and certain blood cancers arising from lymphoid or myeloid lineages. The combined blockade aims to address disease biology that a single-isoform-selective agent might only partially cover.